ConsumerLab.com uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.

About ConsumerLab.com

Posted September 30, 2017

European Union Advisory Council Finds Homeopathic Product Claims "Implausible"

On September 20, 2017, the European Academies' Science Advisory Council (EASAC) published its official analysis and conclusion on the use of homeopathic products, finding a lack of evidence that homeopathic products are effective, and raising concerns about quality control. 

Homeopathy has been in use since the 1700s and is based on the philosophy that diluted substances have the ability to stimulate the body to heal itself. For example, the homeopathic "Law of Similars" states that a substance that produces a certain set of symptoms in a healthy person has the power to cure a sick person manifesting those same symptoms -- although usually the substance is given in minute quantities. 

In its statement, the EASAC issued the following conclusions regarding the efficacy and safety of homeopathic products:
  • Scientific mechanisms of action: The claims for homeopathy are implausible and inconsistent with established scientific concepts


  • Clinical efficacy: A placebo effect may appear in individual patients but we agree with previous extensive evaluations concluding that there are no known diseases for which there is robust, reproducible evidence that homeopathy is effective beyond the placebo effect. There are related concerns for patient-informed consent and for safety, the latter associated with poor quality control in preparing homeopathic remedies.


  • Promotion of homeopathy: May pose significant harm to the patient if incurring delay in seeking evidence-based medical care and that there is a more general risk of undermining public confidence in the nature and value of scientific evidence.


  • Veterinary practice: There is no rigorous evidence to substantiate the use of homeopathy in veterinary medicine and it is particularly worrying when such products are used in preference to evidence-based medicinal products to treat livestock infections.
It also recommended against public health system reimbursement for homeopathic products and practices unless they are demonstrated to be efficacious and safe by rigorous testing and urged that promotional claims for efficacy, safety and quality of homeopathic products should not be made without demonstrable and reproducible evidence.

See related Warnings:

FTC Announces New Enforcement Policy on Homeopathic Drug Claims

Homeopathic Teething Tablets and Gels May Pose Danger, FDA Warns

Don't Rely on Homeopathic Asthma Products, FDA Warns

Homeopathic Company Warned For Drug Claims and Improper Labeling

Homeopathic Manufacturer Settles False Advertising Suit

Homeopathic Products Recalled Due to Allergy Risk

To read the EASAC's complete statement, use the link below.